VA Secretary: $782M needed to start transition to Cerner EHR

David Shulkin, MD, secretary of the U.S. Department of Veterans Affairs, asked a House committee to redirect $782 million of his agency’s budget to begin the switch from the VA’s legacy electronic health record system to a new Cerner platform.

This would require transferring $690 million from the VA’s fiscal year 2018 budget for medical care and $92 million marked for IT projects. Without permission from Congress to redirect these funds, Shulkin said the project’s costs would increase by 5 to 10 percent over the transition period. By starting sooner, it can work in tandem with the Cerner EHR implementation just beginning at the Department of Defense (DoD), where three sites in the Pacific Northwest have gone online with a MHS Genesis platform similar to what the VA plans on installing.

“We will achieve DoD interoperability,” Shulkin said to the House Appropriations Military Construction and VA Subcommittee. “I practice in the VA. I have to leave my system that I use to go into one across the country, so it’s not, even within the VA system, true, easy interoperability.”

Complicating his request for redirecting funds is the fact the Cerner contract hasn’t been signed yet. A lawsuit from rival EHR provider CliniComp was one of the factors blamed for the delay.

Lawmakers questioned Shulkin as to why there’s been a lack of details on the contract, considering Cerner was awarded the VA deal without going through a competitive bidding process.

“We need answers about the true costs and what can be salvaged from what’s already been spent,” said Rep. Rodney Frelinghuysen, R-New Jersey.

According to Federal News Radio, more details about the costs were discussed in a closed session about the public hearing.

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.